DCM
BHVN

Driehaus Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Driehaus Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50,830
Closed -$7.41M – 434
2022
Q2 		$7.41M Buy
+50,830
New +$7.41M 0.12% 234
2022
Q1 		– Sell
-180,126
Closed -$24.8M – 474
2021
Q4 		$24.8M Buy
180,126
+51,180
+40% +$7.05M 0.25% 119
2021
Q3 		$17.9M Buy
+128,946
New +$17.9M 0.21% 147